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A study of plasma renin activity and sodium excretion in nor-
motensive subjects with a previous history of estrogen- or preg-
nancy-associated hypertension. A. A. Al-Khader, E. H. F.
McGale, C. Stewart, and G. M. Aber. Renal Research Labora-
tory, Department of Nephrology, North Staffordshire Hospital
Centre, Stoke-on-Trent, England. Inview of the similar structur-
al and hemodynarnic abnormalities of the intrarenal circulation
noted in patients with a previous history of either estrogen- or
pregnancy-associated hypertension, the present investigation
was designed to study PRA in the supine position, after adopting
an upright posture and after acute and "chronic" sodium deple-
tion induced by a single dose of frusemide (1 mg/kg body weight)
and I week's treatment with bendrofluazide (5 mg/day), respec-
tively, in similar groups of patients. The natriuretic effect of an
i.v. infusion of isotonic saline (300 mmoles in 1 hour) was also
studied. Ten patients with a previous history of estrogen-associ-
ated hypertension and six with a history of pregnancy-associated
hypertension were studied. All were normotensive at the time of
study, and none were taking any therapy likely to influence blood
pressure, sodium balance, or PRA. The results were compared
with those of a control group of 11 subjects, matched for age and
parity. The results demonstrate: (1) Low PRA in the supine posi-
tion occurred with an exaggerated rise on adopting an upright
posture. (2) An increase in PRA occurred in response to both a
single dose of frusemide and after a week's treatment with ben-
drofluazide, both changes being significantly greater than that
seen in the control group (P < 0.05). (3) The increase in PRA
induced by bendrofluazide was associated with significantly
greater reductions in both body weight (P < 0.05) and plasma
potassium (P < 0.05) than were observed in the control subjects.
(4) An exaggerated natriuresis was noted following the i.v. in-
fusion of isotonic saline, in association with a diminished degree
of renin suppression compared with controls. The results sum-
marized above were common to both groups of patients studied.
They suggest that normotensive patients with a previous history
of estrogen- or pregnancy-associated hypertension have distur-
bances of PRA resulting from abnormalities of sodium con-
servation and/or volume perception. The exaggerated natriuresis
associated with an infusion of isotonic saline in these normoten-
sive subjects is similar to that reported in patients with estab-
lished hypertension. The available data do not preclude the pos-
sibility that such disturbances of PRA and sodium excretion may
have actually antedated the complicated pregnancy or the use of
estrogen compounds.
Mechanism involved in gentamicin-induced acute renal failure.
C. Baylis. Department ofPhysiology, University of Manchester,
Manchester, England. Recent observations suggest that the
aminoglycoside antibiotic gentamicin (G) exerts nephrotoxic side
effects in both man and experimental animals. To define the na-
ture and possible causes of the impairment in renal function fol-
lowing G administration, the present studies were performed on
the Munich-Wistar rat, given the drug at a dose of 60 mg/kg body
weight per day for 14 days. During the course of chronic G ad-
ministration to 8 rats the following changes occurred (compared
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with pretreatment control values in the same animals): 24 hr
urine flow rate increased about two-fold, urinary protein and po-
tassium excretion increased twofold to threefold, but sodium ex-
cretion remained essentially unchanged. Marked increases in
blood urea nitrogen have also been reported with G administra-
tion over a similar time course. Acute studies were performed on
the same group of rats on day 15 of G administration and were
compared with those carried out on a normal, weight-matched
control group of 5 animals. Whole kidney GFR was profoundly
reduced in rats given G (0.35 0.03 mlImin compared with
0.95 0.09 mI/mm in controls; P < 0.001). Renal plasma flow
(RPF) and whole kidney filtration fraction (FF) were both signifi-
cantly lower in rats given G compared with controls (1.59 0.25
vs. 2.92 0.43 mllmin, P < 0.025; and 0.24 0.02 vs. 0.32
0.02, P < 0.05, respectively). Despite the reduced GFR in the
treated group, urine flow rate was significantly elevated com-
pared with controls (0.0046 0.0009 vs. 0.0018 0.0002 mLlmin;
P < 0.025). Rats given G had significantly lower urine to plasma
inulin ratios (93 17 vs. 533 45; P < 0.001), indicating
markedly impaired urinary concentrating ability. Thus, adminis-
tration of this dose of 0 to the rat results in a nonoliguric form of
acute renal failure. The decline in GFR observed is due in part to
the observed fall in RPF, since in the rat, GFR is highly depen-
dent on RPF. The concomitant decline in FF with G, however,
indicates additional impairment of one or more of the other de-
terminants of glomerular ultrafiltration. It is probable that a fall
in the glomerular capillary ultrafiltration coefficient, Kf (the prod-
uct of available filtration surface area and the water permeability
of the glomerulus), is the other major determinant of the reduced
GFR seen with G, since even very low doses in this same strain
of rat result in a maximal reduction of Kf to about 50% of normal.
The precise manner in which G (and possibly other nephrotoxic
antibiotics as well) evokes these falls in K and RPF remains to
be defined.
Role of the kidney in silicon metabolism in man. J. W. Dobbie,
M. J. B. Gray, and A. C. Kennedy. Tenovus Kidney Diseases
Research Unit, Royal Infirmary, Glasgow, Scotland. Absorption
and urinary excretion of silicon (S) in health and varying degrees
of renal impairment were determined in 1,000 subjects. S con-
centration in body fluids was measured by atomic absorption
spectroscopy. Initial studies established that in health the kidney
is the main excretory organ for absorbed dietary S. Studies on 30
patients with exteriorized biliary secretion failed to demonstrate
any significant enterohepatic circulation of S. Little variation
was found in serum S in healthy adults (mean, 0.6 pg/mI; SD,
0.15; N 173). In 240 patients with renal disease, a progressive
fall in 24-hour urinary excretion of S occurred with decreasing
creatinine clearance. Serum S of patients on hemodialysis was
twice that of normal controls (mean, 1.2 pg/mI; SD, 0.3; N = 40).
Following transplantation, serum S tended to fall (mean, 1.0 pg/
ml; so, 0.15; N = 30). Prehemodialysis and posthemodialysis
serum S showed a mean fall of 28% in 18 patients after 5 hours'
dialysis. This study has shown that urinary S excretion is depen-
dent on dietary intake and renal function, that serum S rises with






increasing uremia, and that serum S is dialyzable. These findings
may, therefore, be of relevance in renal osteodystrophy in view
of recent claims that S is an essential element in bone formation.
Renal vein renin measurements in normotensive children. K. G.
Gerdts, Vanita Shah, J. M. Savage, and M. J. Dillon. Renal
Unit, The Hospital for Sick Children, Great Ormond Street, Lon-
don, England. Determination of bilateral renal venous renin lev-
els has been established as an important diagnostic procedure to
identify surgically curable forms of hypertension in adults and
children. However, the interpretation of renal vein renin data is
hampered by a lack of information on normal subjects. The defi-
nition of a significant renal vein renin ratio, i.e., the minimum
ratio of plasma renin from the affected (R) over that from the
contralateral kidney (Rc) clearly identifying pathologic lateral-
ization, remains arbitrary. In an attempt to establish a reference
range for renal venous PRA ratios, we have measured renal
venous and caudal inferior vena caval (P) PRA in 49 normoten-
sive children free from renal disease who underwent cardiac
catheterization to elucidate their congenital heart lesions. PRA
was determined by radioimmunoassay of generated angiotensin
1. There was no significant difference between PRA levels in the
renal veins (Student's t = 1.32, P < 0.2). Renal venous PRA was
found to be significantly higher than PRA in the inferior vena
cava (t = 10, P << 0.001). As in studies on hypertensive sub-jects, we calculated RJRc by dividing the higher renal venous
PRA (R) by the value obtained from the contralateral kidney
(Rc), and Re/P correspondingly. A wide variation of Re/P was
observed, with a mean of 1.15 (95% confidence limits, 0.78 to
1.62). Four patients had a renal venous PRA that was at the 95%
probability level lower than PRA in the inferior vena cava. The
possibility of net renin removal by these kidneys is discussed.
We found a mean RJRc of 1.16. Three patients had an R/Rc of
greater than 1.4, the highest value observed being 1.55. These
results support 1.5, the ratio at present most widely accepted for
clinical practice, as the upper limit of normality for the inter-
pretation of renal vein renin measurements.
Analytical techniques applied to the study of sodium excretion in
dogs. D. Gordon, F. S. Nashat, and C. S. Wilcox. Medical Unit,
St. Mary's Hospital Medical School, London, and Department of
Physiology, Middlesex Hospital Medical School, London, Eng-
land. The renal excretion of sodium (UNV) was studied in
anesthetised dogs during acute changes in plasma sodium con-
centration (P) induced by infusion of sodium chloride solutions
of varying concentration through a needle in the renal artery.
Certain other variables known to be capable of influencing UNOV
were also recorded. Principal factor analysis with iteration, fol-
lowed by varimax rotation, defined four "factors," linear func-
tions of the primary variables, that described the inter-
relationships of the primary variables. The aim was to find dis-
crete sets of strongly intercorrelated variables which could
reveal physiologic processes related to UNaV. Factor 1 was
strongly correlated with UaV and PNa its other correlations de-
scribed the acidosis and hypoproteinemia of hypernatremia. Fac-
tor 2 was negatively correlated with UNaV. Its correlations with
plasma protein concentration, GFR, renal plasma flow, hemato-
crit, and blood pressure were such as to imply that it represented
postglomerular plasma protein concentration and its influence on
sodium reabsorption from the tubule. Factors 3 and 4 showed
interrelationships of the variables independent Of UNaV. Multiple
regression analysis with UNaV as the dependent variable and on-
ly Factors 1 and 2 as independent variables gave an equation
with multiple r = 0.74. This explained almost as much of the
change in UNaV as an equation with all the primary variables
expressed individually (r 0.75). Thus, factor analysis clarified
the interpretation of the results of these experiments without loss
of descriptive power. The main influence on UNaV was PNa, this
requiring, for its full expression, concomitant changes in plasma
concentrations of hydrogen ion and protein. The other prime in-
fluence, which is independent of PN, could represent the com-
bined effect of a number of variables on UNV through changes
induced in postglomerular plasma protein concentration.
Rhythms in renal allograft rejection. Martin S. Knapp, J. R.
Cove-Smith, and R. Pownall. Renal Unit, City Hospital, Not-
tingham, England. Rhythmicity occurs in many biologic events.
The frequencies of these rhythms vary from seconds to years,
but most reports in medicine have been concerned with circadian
rhythms with a frequency of around 24 hours. We have recently
described circadian rhythmicity in cell-mediated immune pro-
cesses, and have suggested that there may be a circadian varia-
tion in events associated with renal allograft rejection in man. A
recent report has suggested that renal allograft rejection may
show a 6 to 8 day rhythm. The records of 52 patients who had
received a renal transplant, and had been followed with daily
plasma creatinine estimations for up to 60 days, were analyzed
with plots of the weight-corrected reciprocal of plasma creatinine
against time. This method identifies the time when renal function
changes from an improving or stable state to one of deteriora-
tion, usually due to allograft rejection. Acute changes in func-
tion, not due to obstruction or other complications, were classi-
fied as either possible, probable, or certain rejection episodes.
The day on which renal function first caused a change in plasma
creatinine, not anticipated by the previous sequence of results,
was considered to be the "day of rejection." Data from the first
35 transplant patients reviewed in detail included 22 incidents
considered to be "certain" rejection. In these episodes, the lines
of improving and deteriorating plasma creatinine, expressed as
the reciprocal and analyzed by linear regression, showed correla-
tion coefficients greater than 0.8. These lines, when extrapolat-
ed, met at an acute angle, with the point of intercept indicating
the time when rejection may first have affected creatinine clear-
ance. Such episodes appeared to be more frequent at night than
in the day, and it is suggested that there is a circadian rhythm in
the timing of rejection (P < 0.01). When the whole series of 52
patients was considered, the most frequent interval observed be-
tween the days of "rejection," i.e., the day of onset of decreas-
ing function, was 7 days. We were unable to confirm the sugges-
tion that rejection was most common around the 7th, 14th, 21st,
and 28th days posttransplant, but we did note that the most likely
day for a first rejection episode was between 6 and 8 days after
plasma creatinine had begun to fall, and we suggest that any 7-
day rhythm may be timed from the onset of function rather than
from the day of graft insertion. In summary, a circadian rhythm
in renal allograft "rejection" has been demonstrated. A circasep-
tan ("around 7-day") rhythm in allograft rejection may also be
present. Consideration of these rhythms might permit the design
of therapeutic regimes that are either more effective or less toxic,
or both.
Plasma level and renal clearance of oxalate in normal subjects
and in patients with primary hyperoxaluria and/or chronic renal
failure. P. O'Regan, A. M. Joekes, A. R. Constable, G. P. Ka-
sidas, and G. Alan Rose. St. Peter's Group of Hospitals and
Institute of Urology, London, England. Plasma oxalate has been
measured by two different methods. One method is isotopic and
applicable at all levels of plasma oxalate and renal function. The
other method is enzymatic and only applicable at raised levels of
plasma oxalate. Oxalate clearance and the exchangeable oxalate
pool were also measured. The radionuclide method was applied
to 6 normal volunteers, to 10 patients with chronic renal failure,
to 3 patients who were calcium oxalate stone-formers with
idiopathic hypercalciuria and slightly elevated urinary oxalate
excretion but a normal glycollic acid excretion, and to 7 patients
with primary hyperoxaluria. Some of the latter group were stud-
ied at different stages of treatment, i.e., before and after pyridox-
me, and before and after transplantation. One hyperoxaluric pa-
tient who was the recipient of a successful renal transplant was
studied in detail. In 8 patients whose plasma oxalate was greater
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than 20 moles/liter, the derived isotopic and direct enzymatic
measurements of plasma oxalate were carried out. Where the
isotopic and the enzymatic methods could be applied simultane-
ously, the correlation was good. Raised plasma oxalate and
raised exchangeable oxalate pool were attributable to both pri-
mary hyperoxaluria and chronic renal failure and were seen also
in the 3 stone-formers, who were assumed to be intestinal hyper-
absorbers of oxalic acid, but for any given creatinine clearance
the plasma oxalate and exchangeable oxalate pool were set con-
siderably higher with primary hyperoxaluria than they were with
the other conditions. In most normal subjects and most patients,
the ratio of clearance of oxalate to clearance of creatinine was
greater than 1.
Effect of prostacyclin on platelets in hemodialysis: Dialysis with-
out anticoagulation. H. F. Woods, M. J. Weston, and S. Bunting.
Renal Unit, King's College Hospital, London, and Weilcome
Research Laboratories, Beckenham, Kent, England. Prostacy-
din, produced by vascular endothelium, is the most potent inhib-
itor of platelet function known to man. To assess its effects on
platelet-foreign-surface interactions during hemodialysis, 10
greyhounds were dialyzed with Cuprophan coils (Travenol) and
standard dialysis equipment for 90 mm. At the end of dialysis,
arterial platelet counts (% of initial) in 5 dogs in which prostacy-
din had been infused (115.7 8.6) were significantly higher than
in 5 animals in which heparin alone was given (77.8 16.8) (P <
0.05). Prostacyclin reduced the extraction of platelets by the
dialyzer. The screen filtration pressure of blood leaving the dialy-
zer, a measurement of platelet aggregates and microemboli, was
not elevated in the animals which received prostacyclin
(80 11.3 mm Hg) but rose significantly in those which received
heparin only (249 57 mm Hg) (P < 0.02). In another 5
greyhounds infused with prostacyclin, but which received no
heparin, dialysis was completed without significant clotting with-
in the dialyzer or lines. The platelet count did not fall, the screen
filtration pressure did not rise, and tests of blood clotting were
not altered compared with predialysis values. Thus prostacyclin
prevents platelet activation during hemodialysis and enables
dialysis to be carried out without anticoagulation.
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Angiography of arteriovenous hemodialysis fistulas. P. Aubert,
A. Bernard, J. Bachet, P. Quentric, B. Goudot, and J. Guédon.
C.M.C. Foch 40, Suresnes, France. During the past 5 years, 60
angiographies of hemodialysis arteriovenous fistulas (AAF) were
performed on 32 patients. Three methods were used: retrograde
catheterization through femoral artery (3 cases), direct arterial
cannulation (6 cases), and retrograde venography (51 cases). In-
dications for AAF included insufficient blood flow during dialysis
or poor development of the fistula (30 cases), abnormal return
pressure of the blood during hemodialysis (16 cases), and others
(14 cases). Roentgenographic abnormalities were found in 86.7%
of AAF, which was correlated well with clinical findings in 73%.
Reliable diagnosis was impossible in 8.3% of AAF, mainly be-
cause of inadequate methods, and 5% appeared normal. Roent-
genographic findings identified vascular stenosis (56%) or throm-
bosis (16%), aneurysms (19%), and miscellaneous (9%). AAF
was useful for planning appropriate medical or surgical treatment
in 58% of the studies; in 42%, radiologic abnormalities were
thought to be compatible with prolonged survival of the fistula,
and no treatment was performed. Retrograde venography seems
the method of choice for AAF because it is safe and effective in
most cases.
Urinary lactic deshydrogenase isoenzyme 5 (LDH5) and urinary
tract infection in children. F. Bouissou, P. Barthe, J. P. Thouve-
not, P. Bourely. Service de Médecine Infantile C, Laboratoire de
Biochimie II, Hôpital Purpan, Cedex, France. It has been stated
that an increase in urinary excretion of LDH5 is helpful in topo-
graphic diagnosis of urinary tract infection (UTI). Sixty-three
children (mean age, 6 years) with significant UTI were studied.
They had a significantly higher (P < 0.01) LDH5 excretion than
control subjects free of UTI had (65 normal children, 32 with
renal failure, 29 with the nephrotic syndrome, 88 with uropathy).
The presence of renal failure did not influence the results. A good
correlation was found with inflammatory tests, quantitative bac-
teriologic count, and leucocyturia. No correlation was found
with immunologic parameters (antibody-coated bacteria in urine,
and serum antibodies). According to the results of the preceding
tests and to the presence or not of malformative uropathy, a
quantitative score was attributed to each patient. We found a
significantly (P < 0.02) higher urinary elimination of LDH5 in
patients with high scores (renal infection) than in those with low
scores (bladder infection). We conclude that high urinary LDH5
level does not reflect only renal parenchymal infection. LDFI5
excretion may increase with leucocyturia. Itis only a presump-
tive test, among other techniques, for topographic diagnosis of
UTI. These results conflict with previous data obtained in adult
patients.
Theophylline influence on the ferritin pathway through the gb-
merular basement membrane in the rat. J. Cambar and P.
Gendre. Department of Physiology, U.E.R. of Pharmaceutical
Sciences, Bordeaux, France. The present study compares the
ferritin particle density (particle number/cm2 of micrographic
area) within the capillary lumen and the glomerular basement
membrane (GBM) in rats infused either with isotonic saline solu-
tion (0.15 mlImin flow) (control) or with a 3 mg/mI theophylline
solution (treated). Particle density within the capillary lumen was
25.27 3.93 part./cm2 in control rats and 7.7 2.87 after theo-
phylline infusion (— 228%). Within the GBM, particle density
was 4.68 1.85 part./cm2 in the control rats, whereas it was
17.11 3.9 in the treated animals (+ 265%). Ferritin density in-
crease within the GBM indicates an augmentation in the proteic
tracer passage through the glomerular barrier. This inter-
pretation is confirmed by the parallel decrease in particle density
within the capillary lumen. Many data, which we have recently
described, contribute to explaining the present observations. In-
deed, we have demonstrated that theophylline, as a cyclic AMP
phosphodiesterase inhibitor, increases afferent arteriole diame-
ter and isolated glomeruli diameter, probably by myorelaxant ef-
fect on smooth muscle fibers, thus increasing the cortical blood
flow. Morphometric ultrastructural studies have confirmed diam-
